FIG 5.

HNRNPU-AS1 positively regulated AXIN2 expression. (A) Spearman correlation analysis between AXIN2 expression and HNRNPU-AS1 expression. (B) KM analysis on the OS of AXIN2 in combination with HNRNPU-AS1 in CC patients. (C) KM survival analysis on the OS of AXIN2 combined with HNRNPU-AS1 and miR-205-5p in CC patients. (D and E) RT-qPCR and WB assays on AXIN2 levels in HNRNPU-AS1 inhibition or overexpression groups. (F and G) RT-qPCR and WB assays on AXIN2 levels in AXIN2 inhibition or overexpression group. Data are displayed in the form of means ± SD from 3 individual assays. **, P < 0.01 versus siNC or vector group.